Package 70069-857-01

{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "3bc4f406-2e98-7169-e063-6394a90a81d9", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0370069857014"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["3bc4f406-2ec7-7169-e063-6394a90a81d9"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Somerset Therapeutics LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (70069-857-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS", "package_ndc": "70069-857-01", "marketing_start_date": "20250829"}], "brand_name": "Azacitidine", "product_id": "70069-857_3bc4f406-2e98-7169-e063-6394a90a81d9", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "70069-857", "generic_name": "Azacitidine", "labeler_name": "Somerset Therapeutics LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA217453", "marketing_category": "ANDA", "marketing_start_date": "20250829", "listing_expiration_date": "20261231"}